Company Filing History:
Years Active: 2017-2019
Title: Innovations of Julian Norman Kenyon in Cancer Treatment
Introduction
Julian Norman Kenyon is a notable inventor based in Hampshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. With a total of 2 patents, his work focuses on innovative compositions that aim to enhance cancer treatment efficacy.
Latest Patents
Kenyon's latest patents include a pharmaceutical composition for treating cancer that comprises trypsinogen and/or chymotrypsinogen along with an active agent selected from a selenium compound, a vanilloid compound, and a cytoplasmic glycolysis reduction agent. This invention relates to pharmaceutical compositions containing a protease proenzyme, which can provide a multi-functional approach for treating cancer. The compositions are designed to enhance cell-to-cell adhesion of tumor cells, effect proteolysis of tumor cells, or induce tumor cell apoptosis, differentiation, or immunorecognition. The innovative use of both chymotrypsinogen and trypsinogen as protease proenzymes is a key aspect of his work.
Career Highlights
Throughout his career, Kenyon has worked with various organizations, including the University of Sydney Commercial Development & Industry Partnerships and Propanc Pty Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in pharmaceutical compositions.
Collaborations
Kenyon has collaborated with notable individuals in his field, including Paul Rodney Clayton and David Tosh. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Julian Norman Kenyon's contributions to cancer treatment through his innovative pharmaceutical compositions highlight the importance of research and development in the medical field. His work continues to pave the way for advancements in cancer therapies.